Small-molecule CD73 inhibitors for the immunotherapy of cancer: a patent and literature review (2017–present)
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Small-molecule CD73 inhibitors for the immunotherapy of cancer: a patent and literature review (2017–present)
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC PATENTS
Volume -, Issue -, Pages 1-10
Publisher
Informa UK Limited
Online
2021-04-29
DOI
10.1080/13543776.2021.1923694
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Discovery of Potent and Selective Methylenephosphonic Acid CD73 Inhibitors
- (2021) Ehesan U. Sharif et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of Phelligridin-Based Compounds as Novel Human CD73 Inhibitors
- (2021) Sifan Lyu et al. Journal of Chemical Information and Modeling
- Natural products in drug discovery: advances and opportunities
- (2021) Atanas G. Atanasov et al. NATURE REVIEWS DRUG DISCOVERY
- CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer
- (2021) Nataliia Petruk et al. Scientific Reports
- Structural investigation on thiazolo[5,4-d]pyrimidines to obtain dual-acting blockers of CD73 and adenosine A2A receptor as potential antitumor agents
- (2020) Flavia Varano et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- 2-Substituted α,β-Methylene-ADP Derivatives: Potent Competitive Ecto-5′-nucleotidase (CD73) Inhibitors with Variable Binding Modes
- (2020) Sanjay Bhattarai et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic Anhydrase IX, in Patients With Advanced Solid Tumors
- (2020) Paul C. McDonald et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- CD73 blockade enhances the local and abscopal effects of radiotherapy in a murine rectal cancer model
- (2020) Hidenori Tsukui et al. BMC CANCER
- Blockade of CD73 delays glioblastoma growth by modulating the immune environment
- (2020) J. H. Azambuja et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Exploring the multiple binding modes of inhibitors to carbonic anhydrases for novel drug discovery
- (2020) Claudiu T. Supuran Expert Opinion on Drug Discovery
- Discovery of Potent and Selective Non-Nucleotide Small Molecule Inhibitors of CD73
- (2020) Joel W. Beatty et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of AB680: A Potent and Selective Inhibitor of CD73
- (2020) Kenneth V. Lawson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting Metabolism of Extracellular Nucleotides via Inhibition of Ecto-Nucleotidases CD73 and CD39
- (2020) Jenna L. Jeffrey et al. JOURNAL OF MEDICINAL CHEMISTRY
- Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: Where are we today?
- (2020) Chandra B. Mishra et al. MEDICINAL RESEARCH REVIEWS
- Inhibition of the Adenosine Pathway to Potentiate Cancer Immunotherapy: Potential for Combinatorial Approaches
- (2020) Elizabeth A. Thompson et al. Annual Review of Medicine
- Orally Bioavailable Small-Molecule CD73 Inhibitor (OP-5244) Reverses Immunosuppression through Blockade of Adenosine Production
- (2020) Xiaohui Du et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ectonucleotidase CD73 and CD39 expression in non-small cell lung cancer relates to hypoxia and immunosuppressive pathways
- (2020) Alexandra Giatromanolaki et al. LIFE SCIENCES
- Fluorescent Probes for Ecto-5′-nucleotidase (CD73)
- (2020) Constanze C. Schmies et al. ACS Medicinal Chemistry Letters
- Nucleotide Analog ARL67156 as a Lead Structure for the Development of CD39 and Dual CD39/CD73 Ectonucleotidase Inhibitors
- (2020) Laura Schäkel et al. Frontiers in Pharmacology
- Carbonic Anhydrase Inhibitors Targeting Metabolism and Tumor Microenvironment
- (2020) Andrea Angeli et al. Metabolites
- Comments to the Editor Due to the Response by the Supuran Group to Our Article
- (2020) Bengt-Harald Jonsson et al. BIOPHYSICAL JOURNAL
- A highly potent CD73 biparatopic antibody blocks organization of the enzyme active site through dual mechanisms
- (2020) James E. Stefano et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy
- (2020) Roberta Turiello et al. Journal for ImmunoTherapy of Cancer
- 4-Substituted-1,2,3-triazolo nucleotide analogues as CD73 inhibitors, their synthesis, in vitro screening, kinetic and in silico studies
- (2020) Rayane Ghoteimi et al. BIOORGANIC CHEMISTRY
- Structure–Activity Relationship of Purine and Pyrimidine Nucleotides as Ecto-5′-Nucleotidase (CD73) Inhibitors
- (2019) Anna Junker et al. JOURNAL OF MEDICINAL CHEMISTRY
- An Exceptionally Potent Inhibitor of Human CD73
- (2019) Christine E. Bowman et al. BIOCHEMISTRY
- Virtual Screening Approach for the Identification of Hydroxamic Acids as Novel Human Ecto-5′-Nucleotidase Inhibitors
- (2019) Lucas G. Viviani et al. Journal of Chemical Information and Modeling
- Upregulation of CD73 Confers Acquired Radioresistance and is Required for Maintaining Irradiation-selected Pancreatic Cancer Cells in a Mesenchymal State
- (2019) Anna M. Nguyen et al. MOLECULAR & CELLULAR PROTEOMICS
- Adenosine signaling and the immune system: When a lot could be too much
- (2018) Luca Antonioli et al. IMMUNOLOGY LETTERS
- Targeting the CD73-adenosine axis in immuno-oncology
- (2018) David Allard et al. IMMUNOLOGY LETTERS
- Carbon- versus sulphur-based zinc binding groups for carbonic anhydrase inhibitors?
- (2018) Claudiu T. Supuran JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Ectonucleotidase inhibitors: a patent review (2011-2016)
- (2017) Mariya Al-Rashida et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Structure and function of carbonic anhydrases
- (2016) C. T. Supuran BIOCHEMICAL JOURNAL
- Tenofovir alafenamide (TAF) as the successor of tenofovir disoproxil fumarate (TDF)
- (2016) Erik De Clercq BIOCHEMICAL PHARMACOLOGY
- Inhibition of CD73 AMP hydrolysis by a therapeutic antibody with a dual, non-competitive mechanism of action
- (2016) James C. Geoghegan et al. mAbs
- Targeting CD73 in the tumor microenvironment with MEDI9447
- (2016) Carl M. Hay et al. OncoImmunology
- How many carbonic anhydrase inhibition mechanisms exist?
- (2015) Claudiu T. Supuran JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- α,β-Methylene-ADP (AOPCP) Derivatives and Analogues: Development of Potent and Selective ecto-5′-Nucleotidase (CD73) Inhibitors
- (2015) Sanjay Bhattarai et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ecto-Nucleotidase Inhibitors: Recent Developments in Drug Discovery
- (2015) Younis Baqi MINI-REVIEWS IN MEDICINAL CHEMISTRY
- CD73-Generated Adenosine: Orchestrating the Tumor-Stroma Interplay to Promote Cancer Growth
- (2012) Bertrand Allard et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Virtual Screening Identifies Novel Sulfonamide Inhibitors of ecto-5′-Nucleotidase
- (2012) Peter Ripphausen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cellular function and molecular structure of ecto-nucleotidases
- (2012) Herbert Zimmermann et al. Purinergic Signalling
- Crystal Structure of the Human Ecto-5′-Nucleotidase (CD73): Insights into the Regulation of Purinergic Signaling
- (2012) Karen Knapp et al. STRUCTURE
- (In)organic anions as carbonic anhydrase inhibitors
- (2011) Giuseppina De Simone et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Interfering with pH regulation in tumours as a therapeutic strategy
- (2011) Dario Neri et al. NATURE REVIEWS DRUG DISCOVERY
- CD73: A Novel Target for Cancer Immunotherapy
- (2010) B. Zhang CANCER RESEARCH
- Development of Potent and Selective Inhibitors ofecto-5′-Nucleotidase Based on an Anthraquinone Scaffold
- (2010) Younis Baqi et al. JOURNAL OF MEDICINAL CHEMISTRY
- 5′-Nucleotidases and their new roles in NAD+ and phosphate metabolism
- (2010) Katrina L. Bogan et al. NEW JOURNAL OF CHEMISTRY
- Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis
- (2010) J. Stagg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Long-term (trophic) purinergic signalling: purinoceptors control cell proliferation, differentiation and death
- (2010) G Burnstock et al. Cell Death & Disease
- Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
- (2008) Claudiu T. Supuran NATURE REVIEWS DRUG DISCOVERY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started